TCTMD - tctmd.com
WEBGiven the growing prevalence of heart failure worldwide, we recognize a clear mandate for developing new monitoring strategies and treatment options to increase survival, decrease hospitalizations, and improve quality of life — and for achieving these goals via a variety of potential interventions that target the various contributors to heart ...
TCT 2024 - TCTMD.com
WEBTCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of innovation in research and education that will help doctors save and improve the quality of their patients’ lives.
Injectable Semaglutide Shortage Forces Physicians to Pivot
WEBFeb 5, 2024 · And across the Atlantic, the European Medicines Agency has also put out a notice on a shortage of injectable semaglutide—specifically the Ozempic prefilled pens at doses of 0.25, 0.5, and 1 mg—due to both burgeoning demand and manufacturing issues. The agency said the shortfall is expected to continue through this year.
TCT Connect 2020 - TCTMD.com
WEBOct 14, 2020 · TANGO: A Randomized Dose-Escalation Trial of Temsirolimus Adventitial Delivery to Improve Below the Knee Outcomes. Presenter: Ehrin J. Armstrong. Presentation TCT 2020.
Semaglutide May Ease Tobacco Use, Study Suggests
WEBAug 1, 2024 · Among patients with type 2 diabetes and tobacco use disorder (TUD), results from a real-world study suggest new users of semaglutide (Ozempic; Novo Nordisk) could require fewer healthcare resources to treat their addiction than those on other antidiabetic medications. This, according to researchers led by William Wang (Case Western Reserve ...
Slides | tctmd.com
WEBApr 8, 2024 · Interventional Complications 2023. Seattle, WA. July 14. July 15, 2023. See All Conferences. The best online resource for cardiology conference slides around the globe.
Blood Pressure Insights in COVID-19: Watch for Drops and RAAS …
WEBSep 10, 2020 · Here, Baher Al-Abbasi, MD (University of Miami/JFK Medical Center, Atlantis, FL), and colleagues noted increased in-hospital mortality in 172 COVID-19 patients taking ACE inhibitors or ARBs compared with those not taking the drugs (33% vs 13%; P = 0.003), as well as increased likelihood of admission to the …
COVID-19 Vaccination Tied to Fewer CV Events in Large UK Study
WEBAug 1, 2024 · By Todd Neale. Through one, two, or three doses of COVID-19 vaccine, people who receive the shots generally see lower risks of overall arterial and venous thrombotic events, according to a study of nearly 46 million people living in England. The incidence of major events like acute MI, acute ischemic stroke, pulmonary embolism, and deep venous ...
Micra Leadless Pacemaker Performs Well Through 5 Years
WEBMar 6, 2024 · The Micra VR leadless pacemaker (Medtronic) continues to have a good safety and efficacy profile through the 5-year mark, according to real-world registry data. Rates of major complications and revisions were both under 5%, and no patients required device removal for infection. Moreover, as researchers led by …
St. Jude Medical Furthers the Company’s Legacy of Heart Valve ...
WEBMay 16, 2016 · ST. PAUL, Minn., St. Jude Medical, Inc., a global medical device company, today announced the U.S. launch of the company’s most advanced tissue valve — the Trifecta™ valve with Glide™ Technology (GT) — for the treatment of patients diagnosed with unhealthy, damaged or malfunctioning aortic heart valves.Designed with feedback from a cohort of international physicians, the Trifecta GT ...